Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ZynexZYXIQ Days Payable is 171.68 as of Sep. 2025, which is 131% above its 10-year median of 74.16. The stock has 5 warning signs investors should review.
Zynex's average Accounts Payable for the
three
months ended in Sep. 2025 was $9.9 Mil. Zynex's Cost of Goods Sold for the
three
months ended in Sep. 2025 was $5.3 Mil.
Hence, Zynex's Days Payable for the
three
months ended in Sep. 2025 was 171.68.
The historical rank and industry rank for Zynex's Days Payable or its related term are showing as below:
ZYXIQ'
s Days Payable Range Over the Past 10 Years
Min: 59.05 Med: 74.16 Max: 296.87
Current: 105.64
During the past 13 years, Zynex's highest Days Payable was 296.87. The lowest was 59.05. And the median was 74.16.
ZYXIQ's Days Payable is not ranked
in the Medical Distribution industry.
Industry Median: 76.55
vs ZYXIQ: 105.64
Zynex's Days Payable
increased
from Sep. 2024 (76.95) to Sep. 2025 (171.68).
It may suggest that Zynexdelayed paying its suppliers.
The historical data trend for Zynex's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Zynex's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zynex Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Zynex's Days Payable distribution charts can be found below:
* The bar in red indicates where Zynex's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Zynex's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zynex (ZYXIQ) has a Days Payable of 171.68 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zynex and its competitors. This is 131% above median its historical median of 74.16. Over the past decade, Zynex's Days Payable has ranged from 59.05 to 296.87.
Is Zynex's Days Payable too high?
Zynex's current Days Payable of 171.68 is 131% above median its 10-year median of 74.16. Over the past 10 years, this metric has ranged from a low of 59.05 to a high of 296.87. The Medical Distribution industry median Days Payable is 76.55. Zynex's value of 171.68 is 124.3% above this industry median.
How does Zynex's Days Payable compare to MCK and COR?
Zynex's Days Payable of 171.68 can be compared against companies in the Medical Distribution industry. The industry median Days Payable is 76.55. Zynex's value of 171.68 is 124.3% above this benchmark. Historically, Zynex's own Days Payable has ranged from 59.05 to 296.87 over the past decade. While the company's 10-year median is 74.16 vs. the industry median of 76.55, Zynex has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 76.55, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zynex's current Days Payable of 171.68 is 124.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zynex and its competitors. For the Medical Distribution industry, the median Days Payable is 76.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zynex's current Days Payable is 171.68, which is 131% above median its own 10-year median of 74.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zynex stock overvalued right now?
Zynex (ZYXIQ) has a current Days Payable of 171.68. The stock's GF Value™ is $5.54, compared to a current price of $0.06 — trading 99% below its estimated fair value. The current Days Payable is 171.68, which is 131% above median its 10-year median of 74.16 and 124.3% above the Medical Distribution industry median of 76.55. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zynex (ZYXIQ), the current Days Payable is 171.68 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZYXIQ has been successfully added to your 
